The US is expected to approve the UK-backed AstraZeneca-Oxford Covid vaccine in April, a senior official said.
Moncef Slaoui, the chief advisor to Operation Warp Speed, the military-led US effort for vaccines, said, that the US trials and assessments would be complete for approval 'sometime in early April.'
He further praised Britain's regulatory agency as 'science-based', and said he wasn't questioning the decision they had made in terms of vaccine approval to AstraZeneca-Oxford.
Delhi records 7,897 fresh Covid-19 cases, positivity rate mounts to 10.21%
UP records highest daily spike since Covid-19 outbreak
No lockdown, but new curbs to be imposed soon: Delhi CM on Covid-19 surge
Situation mismanaged by allowing Covid-19 vaccine export: Sonia attacks Centre
Egoistic govt is allergic to good suggestions: Rahul slams Centre over Covid surge
Greta Thunberg says she will not attend COP26 climate summit
Mandatory RT-PCR tests for officials at Wankhede
Poll-bound West Bengal witnesses 15% surge in daily Covid-19 count
Sputnik V vaccine import talks proceed, price negotiations on with Govt
Kangana Ranaut's ‘Thalaivi’ release postponed amid rising Covid-19 cases
India logs 1,45,384 new COVID-19 cases, highest-ever daily spike
EU regulator puts J&J’s Covid vaccine under review after blood clots
Pfizer requests USFDA clearance for vaccine in 12-15 year old kids
Facebook to turn Menlo Park Headquarters into vaccination site
Mumbai to keep all private vaccination centres shut for next three days
Big spike in Delhi's Covid-19 cases, over 8,500 cases in 24 hours
All Delhi schools shut amid worrying spike in Covid cases
Train services will not be stopped, says Railways as migrants head home
Nitish Kumar: arrangements being made for migrants returning to Bihar
Maharashtra CM to take final call on imposing lockdown on Saturday